[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![nimeshscnbc Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::4687762273.png) Nimesh Shah [@nimeshscnbc](/creator/twitter/nimeshscnbc) on x 68.5K followers
Created: 2025-06-13 01:56:14 UTC

Kotak Inst Eqt on Dr Reddys
Reduce, TP Rs 1250
Est. gRevlimid contributed XX% to Co’s FY2025 EPS on a more normalized cost base
This is a big void to fill, which is unlikely to be bridged by Rs9 EPS from GLP-1 (in base case) in FY2027E
@ekta_batra @CNBCTV18News @CNBCTV18Live


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1933342616571331065/c:line.svg)

**Related Topics**
[void](/topic/void)
[rs](/topic/rs)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/nimeshscnbc/status/1933342616571331065)